Filing Details

Accession Number:
0001773751-24-000146
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-21 16:40:50
Reporting Period:
2024-05-20
Accepted Time:
2024-05-21 16:40:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773751 Hims & Hers Health Inc. HIMS Services-Offices & Clinics Of Doctors Of Medicine (8011) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1837817 Soleil Boughton 2269 Chestnut Street, #523
San Francisco CA 94123
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-05-20 4,915 $5.01 164,272 No 4 M Direct
Class A Common Stock Disposition 2024-05-20 4,915 $20.01 159,357 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (right to buy) Disposition 2024-05-20 4,915 $0.00 4,915 $5.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
964,076 2032-02-23 No 4 M Direct
Footnotes
  1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 10, 2023 by the Reporting Person.
  2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.045. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.